Once-versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma

被引:157
作者
Reeder, Craig B. [1 ]
Reece, Donna E. [2 ]
Kukreti, Vishal [2 ]
Chen, Christine [2 ]
Trudel, Suzanne [2 ]
Laumann, Kristina [3 ]
Hentz, Joseph [3 ]
Pirooz, Nicholas A. [1 ]
Piza, Jesus G. [2 ]
Tiedemann, Rodger [1 ]
Mikhael, Joseph R. [1 ]
Bergsagel, Peter L. [1 ]
Leis, Jose F. [1 ]
Fonseca, Rafael [1 ]
Stewart, Alexander K. [1 ]
机构
[1] Mayo Clin, Scottsdale, AZ USA
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Mayo Clin, Mayo Canc Ctr, Dept Biostat, Rochester, MN USA
关键词
DEXAMETHASONE; CYCLOPHOSPHAMIDE; COMBINATION; TRIAL;
D O I
10.1182/blood-2010-02-271676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3416 / 3417
页数:3
相关论文
共 7 条
[1]  
Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x
[2]  
KUMAR S, 2008, BLOOD, V112, pA91
[3]   PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma [J].
Oakervee, HE ;
Popat, R ;
Curry, N ;
Smith, P ;
Morris, C ;
Drake, M ;
Agrawal, S ;
Stec, J ;
Schenkein, D ;
Esseltine, DL ;
Cavenagh, JD .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (06) :755-762
[4]   Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma [J].
Reece, Donna E. ;
Rodriguez, Giovanni Piza ;
Chen, Christine ;
Trudel, Suzanne ;
Kukreti, Vishal ;
Mikhael, Joseph ;
Pantoja, Mariela ;
Xu, Wei ;
Stewart, A. Keith .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4777-4783
[5]   Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial [J].
Reeder, C. B. ;
Reece, D. E. ;
Kukreti, V. ;
Chen, C. ;
Trudel, S. ;
Hentz, J. ;
Noble, B. ;
Pirooz, N. A. ;
Spong, J. E. ;
Piza, J. G. ;
Zepeda, V. H. J. ;
Mikhael, J. R. ;
Leis, J. F. ;
Bergsagel, P. L. ;
Fonseca, R. ;
Stewart, A. K. .
LEUKEMIA, 2009, 23 (07) :1337-1341
[6]  
RICHARDSON P, 2008, BLOOD, V112, pA92
[7]   Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma [J].
Wang, M. ;
Giralt, S. ;
Delasalle, K. ;
Handy, B. ;
Alexanian, R. .
HEMATOLOGY, 2007, 12 (03) :235-239